US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

25.58

+1.476.10%

Post-market: 25.580.00000.00%17:29 EDT

Volume:1.55M

Turnover:39.15M

Market Cap:3.08B

PE:-8.86

High:25.80

Open:24.04

Low:23.66

Close:24.11

Loading ...

Overview Company News Filings

Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?

Wave Life Sciences Advances in RNA Editing Innovations

Sarepta Announces Q4 2024 Revenue Of $638.2M, Exceeding Guidance; ELEVIDYS Revenue At $384.2M; RNA PMO Revenue At $254M; FY24 Revenue Totals $1.79B; $1.5B In Cash And Investments At Year-End 2024; Reiterates 2025 Revenue Guidance Of $2.9B-$3.1B

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update

Analysts Offer Insights on Healthcare Companies: Avidity Biosciences (RNA), Celldex (CLDX) and Centessa Pharmaceuticals (CNTA)

ProQR’s Strategic Focus on RNA Editing for Liver Disease: Targeting PNPLA3 in the MASH Space

Avidity Biosciences Price Target Maintained With a $72.00/Share by HC Wainwright & Co.

Circio Holding ASA Registers Share Capital Increase to Boost RNA Therapeutics and Cancer Vaccine Research

Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Tecan Group AG (OtherTCHBF) and Avidity Biosciences (RNA)

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tempus, Genialis Collaborate to Advance RNA-Based Biomarker Algorithms for Cancer Treatment

MT Newswires Live

Avidity Biosciences Plans to Submit First Biologics License Application This Year

MT Newswires Live

BRIEF-Avidity Biosciences Confirms Accelerated Approval Path for Del-Zota with BLA Planned For Year End 2025

Avidity Biosciences: Accelerated Approval Path Confirmed for Del-Zota; Bla Submission Planned for Year End 2025

THOMSON REUTERS

Press Release: Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025

Tempus AI teams with Genialis to develop RNA-based biomarker algorithms

Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RNA/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","market":"US","secType":"STK","nameCN":"Avidity Biosciences, Inc.","latestPrice":25.58,"timestamp":1744401600000,"preClose":24.11,"halted":0,"volume":1550284,"hourTrading":{"tag":"盘后","latestPrice":25.58,"preClose":25.58,"latestTime":"17:29 EDT","volume":20187,"amount":516404.58,"timestamp":1744406993633},"delay":0,"floatShares":92698253,"shares":120212301,"eps":-2.888476,"marketStatus":"Market Closed","change":1.47,"latestTime":"04-11 16:00:00 EDT","open":24.04,"high":25.8,"low":23.66,"amount":39152068.955248,"amplitude":0.08876,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.888476,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1744617600000},"marketStatusCode":7,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":24.11,"preHourTrading":{"tag":"盘前","latestPrice":24,"preClose":24.11,"latestTime":"09:29 EDT","volume":1146,"amount":27516.68049,"timestamp":1744378199911},"postHourTrading":{"tag":"盘后","latestPrice":25.58,"preClose":25.58,"latestTime":"17:29 EDT","volume":20187,"amount":516404.58,"timestamp":1744406993633},"volumeRatio":0.6918568284707005,"impliedVol":0.7162,"impliedVolPercentile":0.6534},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RNA\",,,,,undefined,":{"symbol":"RNA","floatShares":92698253,"roa":"-21.60%","roe":"-33.47%","lyrEps":-2.888476,"volumeRatio":0.6918568284707005,"shares":120212301,"dividePrice":0,"high":25.8,"amplitude":0.08876,"preClose":24.11,"low":23.66,"week52Low":21.51,"pbRate":"2.16","psRate":"282.19","week52High":56,"institutionHeld":0,"latestPrice":25.58,"eps":-2.888476,"divideRate":0,"volume":1550284,"delay":0,"ttmEps":-2.888476,"open":24.04,"prevYearClose":29.08,"prevWeekClose":26.57,"prevMonthClose":29.52,"prevQuarterClose":29.52,"fiveDayClose":26.57,"twentyDayClose":31.11,"sixtyDayClose":27.87},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RNA\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2503556209","title":"Is Wave Life Sciences (WVE) the Top Small Cap Stock to Buy with the Highest Upside Potential?","url":"https://stock-news.laohu8.com/highlight/detail?id=2503556209","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503556209?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:31","pubTimestamp":1736803905,"startTime":"0","endTime":"0","summary":"We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are going to take a look at where Wave Life Sciences Ltd.  stands against other top small cap stocks to buy with the highest upside potential.What Would 2025 Look Like for Small Cap Stocks?He also believed that the market is likely to come back to earnings. Vendig explained that the market is expected to be choppy in the first few months of 2025. This trend is likely to materialize throughout the first half of 2025, with the choppiness attributed to policy uncertainties. But Vendig believed that if earnings remain intact, he will likely stay constructive on stocks. He even thinks that bonds might be a good opportunity as well. He said:. Why do we care about what hedge funds do?The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small ca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wave-life-sciences-wve-top-213145524.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1674673691.USD","LU1929549753.HKD","BK4550","LU1989772840.SGD","USAW.SI","TQQQ","MNQmain","LU1093756168.USD","LU1674673428.USD","LU1162221912.USD","NQmain","BK4505","BK4566","BK4585","LU1778281490.HKD","LU1069344957.HKD","USJW.SI","RNA","IE00B1XK9C88.USD","QID","BK4567","LU0354030438.USD",".IXIC","LU1035775433.USD","LU0234572021.USD","BK4533","LU1496350171.SGD","LU0320765646.SGD","BK4588","QLD","LU0868494617.USD","TSYW.SI","LU0820561818.USD","PSQ","IE00BSNM7G36.USD","NVIW.SI","WVE","BK4139","LU2756315664.SGD","LU0823434583.USD","LU1093756325.SGD","LU0689472784.USD","SQQQ","HD","LU0943347566.SGD","LU1551013425.SGD","BK4083","LU0823434740.USD","BK4581"],"gpt_icon":1},{"id":"2503371715","title":"Wave Life Sciences Advances in RNA Editing Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2503371715","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503371715?lang=en_us&edition=fundamental","pubTime":"2025-01-14 03:27","pubTimestamp":1736796479,"startTime":"0","endTime":"0","summary":"Wave Life Sciences ( ($WVE) ) just unveiled an announcement. Wave Life Sciences has achieved significant advancements in RNA editing, including the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/wave-life-sciences-advances-in-rna-editing-innovations?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/wave-life-sciences-advances-in-rna-editing-innovations?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","RNA","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2503533239","title":"Sarepta Announces Q4 2024 Revenue Of $638.2M, Exceeding Guidance; ELEVIDYS Revenue At $384.2M; RNA PMO Revenue At $254M; FY24 Revenue Totals $1.79B; $1.5B In Cash And Investments At Year-End 2024; Reiterates 2025 Revenue Guidance Of $2.9B-$3.1B","url":"https://stock-news.laohu8.com/highlight/detail?id=2503533239","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503533239?lang=en_us&edition=fundamental","pubTime":"2025-01-14 01:26","pubTimestamp":1736789212,"startTime":"0","endTime":"0","summary":"– Preliminary total net product revenue of $638.2 million for the fourth quarter and $1.79 billion for full-year 2024, exceeding full-year guidance by over $100 million– Preliminary ELEVIDYS net product revenue totaled","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/01/42954583/sarepta-announces-q4-2024-revenue-of-638-2m-exceeding-guidance-elevidys-revenue-at-384-2m-rna-pmo-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PMO","SRPT","RNA"],"gpt_icon":0},{"id":"2503839635","title":"Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2503839635","media":"ACCESSWIRE","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503839635?lang=en_us&edition=fundamental","pubTime":"2025-01-13 22:20","pubTimestamp":1736778000,"startTime":"0","endTime":"0","summary":"CHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc.  , a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has entered into a distribution agreement with Virax Biolabs Group Limited   to distribute Virax-branded Avian Influenza Virus  Real-Time PCR Kits across various major European markets and certain Gulf Cooperation Council  countries.Specifically, Cosmos Health gains exclusive rights to distribute these kits in Greece and Cyprus, as well as non-exclusive rights in select European countries, including France, Portugal, Spain, The Netherlands, Belgium, Sweden, Finland, Denmark, Norway, Germany, Switzerland, and Austria. The agreement also grants non-exclusive distribution rights in certain Gulf Cooperation Council  countries, namely Oman and Bahrain.According t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cosmos-health-secures-exclusive-distribution-142000620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SLCT","VRAX","BK4175","BK4139","BK4583","COSM","BK4505","GCC","BK4585","BK4588","RNA"],"gpt_icon":0},{"id":"2503309402","title":"Korro Bio Announces Dosing of First Participants in REWRITE Phase 1/2a Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency and Provides Pipeline Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2503309402","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503309402?lang=en_us&edition=fundamental","pubTime":"2025-01-13 21:00","pubTimestamp":1736773200,"startTime":"0","endTime":"0","summary":"KRRO-110 is the first product candidate from Korro’s proprietary RNA editing OPERATM platform. Interim readout from REWRITE expected in the second half of 2025. Korro to advance additional pipeline programs towards clinical development. “We have evolved from a research organization to a clinical-stage drug development organization with our first participant in the REWRITE study recently dosed with KRRO-110. We have taken time to build our pipeline to demonstrate the versatility of RNA editing, building on data from other oligonucleotide programs,” said Ram Aiyar, PhD, President and CEO. “Over the next three years, we expect to take three product candidates into the clinic, in two tissue types with a single modular platform. This will be the crux of our 3-2-1 strategy through 2027. I am excited about the prospect that RNA editing holds beyond the treatment of rare genetic disease and applying our platform to highly prevalent diseases.”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/korro-bio-announces-dosing-first-130000332.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["KRRO","BK4585","RNA","BK4505","BK4588","BK4139"],"gpt_icon":0},{"id":"2503446340","title":"Analysts Offer Insights on Healthcare Companies: Avidity Biosciences (RNA), Celldex (CLDX) and Centessa Pharmaceuticals (CNTA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503446340","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503446340?lang=en_us&edition=fundamental","pubTime":"2025-01-13 14:14","pubTimestamp":1736748852,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avidity Biosciences (RNA – Research Report), Celldex...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avidity-biosciences-rna-celldex-cldx-and-centessa-pharmaceuticals-cnta?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-avidity-biosciences-rna-celldex-cldx-and-centessa-pharmaceuticals-cnta?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","BK4137","CLDX","HCSG","BK4585","BK4139","BK4505","BK4588","CNTA","RNA","BK4539"],"gpt_icon":0},{"id":"2503390219","title":"ProQR’s Strategic Focus on RNA Editing for Liver Disease: Targeting PNPLA3 in the MASH Space","url":"https://stock-news.laohu8.com/highlight/detail?id=2503390219","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503390219?lang=en_us&edition=fundamental","pubTime":"2025-01-13 06:55","pubTimestamp":1736722515,"startTime":"0","endTime":"0","summary":"JMP Securities analyst Jonathan Wolleben reiterated a Buy rating on ProQR (PRQR – Research Report) today and set a price target of $8.00. Jonathan ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/proqrs-strategic-focus-on-rna-editing-for-liver-disease-targeting-pnpla3-in-the-mash-space?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/proqrs-strategic-focus-on-rna-editing-for-liver-disease-targeting-pnpla3-in-the-mash-space?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4585","BK4588","BK4139","RNA"],"gpt_icon":0},{"id":"2502500468","title":"Avidity Biosciences Price Target Maintained With a $72.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2502500468","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502500468?lang=en_us&edition=fundamental","pubTime":"2025-01-10 20:48","pubTimestamp":1736513280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RNA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 10, 2025 07:48 ET (12:48 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNA"],"gpt_icon":0},{"id":"2502914410","title":"Circio Holding ASA Registers Share Capital Increase to Boost RNA Therapeutics and Cancer Vaccine Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2502914410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502914410?lang=en_us&edition=fundamental","pubTime":"2025-01-09 18:03","pubTimestamp":1736417016,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Targovax ASA ( ($GB:0RIS) ). Circio Holding ASA has successfully registered a share capital increase following ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/circio-holding-asa-registers-share-capital-increase-to-boost-rna-therapeutics-and-cancer-vaccine-research?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/circio-holding-asa-registers-share-capital-increase-to-boost-rna-therapeutics-and-cancer-vaccine-research?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASA","BK4585","BK4139","LENZ","BK4505","BK4588","RNA"],"gpt_icon":0},{"id":"2502099634","title":"Analysts Offer Insights on Healthcare Companies: NeuroPace (NPCE), Tecan Group AG (OtherTCHBF) and Avidity Biosciences (RNA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502099634","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502099634?lang=en_us&edition=fundamental","pubTime":"2025-01-09 17:50","pubTimestamp":1736416220,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on NeuroPace (NPCE – Research Report), Tecan Group AG...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neuropace-npce-tecan-group-ag-othertchbf-and-avidity-biosciences-rna?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neuropace-npce-tecan-group-ag-othertchbf-and-avidity-biosciences-rna?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","TCGGY","AG","RNA","HCSG","BK4121","BK4139","BK4137","NPCE","BK4585","BK4539","BK4210","BK4588","BK4082"],"gpt_icon":0},{"id":"2502088040","title":"Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502088040","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502088040?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:05","pubTimestamp":1736370303,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUA7G5GDB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","RNA","BK4505","BK4588"],"gpt_icon":0},{"id":"2502835140","title":"Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2502835140","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502835140?lang=en_us&edition=fundamental","pubTime":"2025-01-09 05:05","pubTimestamp":1736370300,"startTime":"0","endTime":"0","summary":"SAN DIEGO, Jan. 8, 2025 /PRNewswire/ --Avidity Biosciences, Inc. , a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates , today announced that onJanuary 6, 2025,the Human Capital Management Committee of Avidity's Board of Directors granted a non-qualified stock option award to purchase an aggregate of 80,000 shares of its common stock and 40,000 restricted stock units  to Charles Calderaro III, under the Avidity Biosciences, Inc. 2022 Employment Inducement Incentive Award Plan , in connection with Mr. Calderaro's hiring and appointment as Avidity's Chief Technical Officer. The awards were granted as inducements material to Mr. Calderaro entering into employment with Avidity in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/avidity-biosciences-announces-inducement-grants-210500990.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/avidity-biosciences-announces-inducement-grants-210500990.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2095319765.USD","BK4139","RNA","LU2210149790.SGD","NDAQ","IE00B64PRP62.GBP","BK4505","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2210150020.SGD",".IXIC","BK4585","BK4588"],"gpt_icon":0},{"id":"2502705841","title":"Tempus, Genialis Collaborate to Advance RNA-Based Biomarker Algorithms for Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2502705841","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502705841?lang=en_us&edition=fundamental","pubTime":"2025-01-09 01:42","pubTimestamp":1736358137,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) said Wednesday it entered a multi-year collaboration with Genialis to advance the development and validation of RNA-based biomarker algorithms for cancer treatment.Financial details we","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7095","TEM.AU","RNA","TEM","BK4121"],"gpt_icon":1},{"id":"2502772082","title":"Avidity Biosciences Plans to Submit First Biologics License Application This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2502772082","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502772082?lang=en_us&edition=fundamental","pubTime":"2025-01-09 00:23","pubTimestamp":1736353391,"startTime":"0","endTime":"0","summary":"Avidity Biosciences  said Wednesday it plans to file a biologics license application for delpacibart zotadirsen, or del-zota, for patients with Duchenne muscular dystrophy mutations amenable to exon 44 skipping for year end.The US Food and Drug Administration confirmed the accelerated approval path is available for del-zota and that the clinical data package from the EXPLORE44 program could support a BLA filing, the company said.\"We look forward to an exciting year ahead as we prepare to become a commercial organization,\" said Chief Executive Officer Sarah Boyce.Avidity also said it is on track to complete enrollment in del-desiran HARBOR Phase 3 and potential registrational del-brax biomarker cohort as well as initiate global pivotal trial for del-brax by mid-2025.The company said Eric Mosbrooker expanded his role to chief commercial officer to lead its multiple product launches. It also said Charles Calderaro III has joined the firm as chief technical officer, and Kat Lange as chief ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","RNA","BK4588","BK4505","BK4139"],"gpt_icon":0},{"id":"2501773620","title":"BRIEF-Avidity Biosciences Confirms Accelerated Approval Path for Del-Zota with BLA Planned For Year End 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501773620","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501773620?lang=en_us&edition=fundamental","pubTime":"2025-01-08 22:39","pubTimestamp":1736347157,"startTime":"0","endTime":"0","summary":"BRIEF-Avidity Biosciences Confirms Accelerated Approval Path for Del-Zota with BLA Planned For Year End 2025Jan 8  - Avidity Biosciences Inc RNA.O:AVIDITY BIOSCIENCES: ACCELERATED APPROVAL PATH CONFIRMED FOR DEL-ZOTA; BLA SUBMISSION PLANNED FOR YEAR END 2025Source text: nPn2BTczXaFurther company coverage: RNA.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nFWN3O40AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4585","RNA","BK4588","BK4139"],"gpt_icon":0},{"id":"2501720666","title":"Avidity Biosciences: Accelerated Approval Path Confirmed for Del-Zota; Bla Submission Planned for Year End 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501720666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501720666?lang=en_us&edition=fundamental","pubTime":"2025-01-08 22:03","pubTimestamp":1736344997,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nFWN3O40AP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4585","BK4588","BK4139","RNA"],"gpt_icon":0},{"id":"2501720574","title":"Press Release: Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501720574","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501720574?lang=en_us&edition=fundamental","pubTime":"2025-01-08 22:00","pubTimestamp":1736344800,"startTime":"0","endTime":"0","summary":"Avidity Biosciences Plans First BLA Submission and Accelerates Commercialization Preparations for Three Rare Muscle Disease Programs in 2025. Accelerated approval path confirmed for del-zota; Biologics License Application  submission planned for year end 2025. On track to complete enrollment in del-desiran HARBOR Phase 3 and potential registrational del-brax biomarker cohort as well as initiate global pivotal trial for del-brax by mid-2025. Eric Mosbrooker expands role to Chief Commercial Officer; Charles Calderaro III, Chief Technical Officer, and Kat Lange, Chief Business Officer, join as company prepares for global commercialization and continued pipeline expansion. Avidity to present at 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14. Expanding the Leadership Team to Support Anticipated Growth","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","R","BK4127","LU1989772840.SGD","LU1720051017.SGD","LU2089284900.SGD","BK4139","BK4099","LU0158827948.USD","LU1363072403.SGD","LU2347655156.SGD","LU0314104364.USD","LU2357125470.USD","BK4504","LU2271345857.HKD","LU2357305700.SGD","BK4555","LU2111349929.HKD","BK4581","LU0006306889.USD","LU2249611893.SGD","LU2023251221.USD","TM","LU0971096721.USD","LU0795875169.SGD","BK4516","BK4585","LU1074936037.SGD","BK4505","LU0225283273.USD","LU1162221912.USD","03160","CCO","LU0823414551.USD","BK4232","LU2506951792.HKD","BK4009","LU0158827781.USD","LU0267386448.USD","RNA","LU0320765646.SGD","LU2089283258.USD","LU2294711713.HKD","LU1989772923.USD","LU0912757837.SGD","CTO","LU1668664300.SGD","LU1548497426.USD","LU1720051108.HKD","LU0823414478.USD"],"gpt_icon":0},{"id":"2501727055","title":"Tempus AI teams with Genialis to develop RNA-based biomarker algorithms","url":"https://stock-news.laohu8.com/highlight/detail?id=2501727055","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501727055?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:46","pubTimestamp":1736343987,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM), announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ m...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-teams-with-genialis-to-develop-rna-based-biomarker-algorithms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-teams-with-genialis-to-develop-rna-based-biomarker-algorithms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4121","BK4505","RNA","BK4588","BK4585","TEM"],"gpt_icon":0},{"id":"2501271287","title":"Tempus Announces a Collaboration With Genialis to Develop RNA-Based Biomarker Algorithms","url":"https://stock-news.laohu8.com/highlight/detail?id=2501271287","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501271287?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:30","pubTimestamp":1736343000,"startTime":"0","endTime":"0","summary":"CHICAGO, January 08, 2025----Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced a collaboration with Genialis, the RNA-biomarker company. The multi-year agreement allows Genialis to leverage Tempus’ multimodal dataset to develop new RNA-based algorithms across cancer types.\"We look forward to working with Genialis and demonstrating new ways in which our data can be applied to further a new kind of research, one that embraces the power that RNA-based biomarkers can have on the future of cancer care,\" said Kate Sasser, Ph.D., Chief Scientific Officer at Tempus. \"Multimodal algorithms, including RNA signatures, are demonstrating rapid advancement in clinical utility for personalized treatment decisions, and we are excited to partner with Genialis to fuel this data-driven precision medicine future with our xR assay and vast multimodal dataset.\". \"Biomarkers have the potential to transform how cancer is diagnosed","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tempus-announces-collaboration-genialis-develop-133000470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4121","TEM","RNA"],"gpt_icon":1},{"id":"2501080112","title":"Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2501080112","media":"PR Newswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501080112?lang=en_us&edition=fundamental","pubTime":"2025-01-07 20:00","pubTimestamp":1736251200,"startTime":"0","endTime":"0","summary":"-- Collaboration to leverage Orna's differentiated lipid nanoparticle  delivery solutions for patients with SCD and TDT --. -- Orna to receive an upfront payment and is eligible to receive potential pre-clinical, clinical, and commercialization milestone payments and royalties --. WATERTOWN, Mass., Jan. 7, 2025 /PRNewswire/ -- Orna Therapeutics  announced a three-year strategic research collaboration with Vertex Pharmaceuticals Incorporated  to utilize Orna's novel and proprietary LNP delivery solutions to enhance Vertex's efforts in developing next generation gene editing therapies for patients with SCD and TDT.About Orna TherapeuticsOrna Therapeutics is dedicated to designing and delivering a new class of fully engineered circular RNA  therapeutics to unlock the potential of RNA medicine to treat diseases anywhere in the body. Orna's circular RNA transcripts have advantages over traditional mRNA approaches, including simplified production, improved formulation into lipid nano","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/orna-therapeutics-establishes-strategic-collaboration-120000979.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/orna-therapeutics-establishes-strategic-collaboration-120000979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B894F039.SGD","LU1093756168.USD","LU2362540622.SGD","LENZ","LU0061475181.USD","BK4585","LU0889565916.HKD","LU1093756325.SGD","LU0320765992.SGD","LU0417517546.SGD","LU0566484027.USD","LU2362541513.USD","LU0109394709.USD","SCD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU1430594728.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","LU0058720904.USD","LU1035775433.USD","BK4533","BK4532","LU1069344957.HKD","LU2456880835.USD","IE0002141913.USD","BK4023","IE0002270589.USD","LU2324357040.USD","IE00B2B36J28.USD","LU2417539215.USD","LU0289739699.SGD","LU0079474960.USD","LU0256863811.USD","VERX","IE00B19Z3581.USD","LU2362541273.HKD","BK4588","RNA","IE00BJJMRZ35.SGD","BK4139","LU2462157665.USD","LU2237438978.USD","LU1559883803.SGD","VRTX","IE0009355771.USD","IE00B19Z9P08.USD","BK4567","LU1585245621.USD","LU0234570918.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RNA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-27","symbol":"RNA","fiscalQuarterEnding":"2024/12","expectedEps":-0.84,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2024-11-07","symbol":"RNA","fiscalQuarterEnding":"2024/09","expectedEps":-0.79,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-08-09","symbol":"RNA","fiscalQuarterEnding":"2024/06","expectedEps":-0.76,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723176000000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2024-05-09","symbol":"RNA","fiscalQuarterEnding":"2024/03","expectedEps":-0.81,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.79},{"market":"US","date":"2024-02-28","symbol":"RNA","fiscalQuarterEnding":"2023/12","expectedEps":-0.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709096400000,"reportTimeType":"post","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RNA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RNA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1538,"buy":0.8462,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8462,"analysts":13,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RNA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RNA","date":"2025-04-11","current":-8.992555,"percent":0.576826,"low":-41.796609,"twenty":-20.563174,"median":-11.12911,"eighty":-5.018968,"high":-1.864956,"avg":-13.178504,"sd":9.291751,"marketCap":2898318577},"quantilePoints":[{"date":"2020-06-12","current":-35.638406,"twenty":-29.775182,"median":-20.980345,"eighty":-20.980345,"marketCap":1007497743},{"date":"2020-06-19","current":-39.899176,"twenty":-39.116319,"median":-35.96886,"eighty":-26.843569,"marketCap":1127949695},{"date":"2020-06-26","current":-35.321452,"twenty":-39.755873,"median":-37.152541,"eighty":-35.448234,"marketCap":998537442},{"date":"2020-07-02","current":-35.653171,"twenty":-39.328619,"median":-36.138594,"eighty":-35.384843,"marketCap":1007915142},{"date":"2020-07-10","current":-35.746052,"twenty":-38.41042,"median":-36.382953,"eighty":-35.641359,"marketCap":1010540898},{"date":"2020-07-17","current":-34.352832,"twenty":-38.00705,"median":-36.138594,"eighty":-35.045462,"marketCap":971154560},{"date":"2020-07-24","current":-31.486779,"twenty":-37.457723,"median":-35.838933,"eighty":-32.192677,"marketCap":890131236},{"date":"2020-07-31","current":-37.404648,"twenty":-37.478953,"median":-36.117578,"eighty":-33.328484,"marketCap":1057429395},{"date":"2020-08-07","current":-38.121161,"twenty":-37.815979,"median":-36.147989,"eighty":-33.816774,"marketCap":1077685226},{"date":"2020-08-14","current":-32.261103,"twenty":-37.539989,"median":-35.87874,"eighty":-32.619559,"marketCap":1087521766},{"date":"2020-08-21","current":-33.897535,"twenty":-37.478953,"median":-35.772589,"eighty":-32.619559,"marketCap":1142685913},{"date":"2020-08-28","current":-31.749022,"twenty":-37.383418,"median":-35.638406,"eighty":-31.8314,"marketCap":1070259516},{"date":"2020-09-04","current":-31.949401,"twenty":-37.295844,"median":-35.095883,"eighty":-31.869249,"marketCap":1077014309},{"date":"2020-09-11","current":-37.281723,"twenty":-37.285229,"median":-35.268377,"eighty":-31.949401,"marketCap":1256766872},{"date":"2020-09-18","current":-38.194563,"twenty":-37.497529,"median":-35.653171,"eighty":-32.060723,"marketCap":1287538709},{"date":"2020-09-25","current":-32.45035,"twenty":-37.497529,"median":-35.645789,"eighty":-32.160913,"marketCap":1093901293},{"date":"2020-10-02","current":-31.860343,"twenty":-37.404648,"median":-35.215302,"eighty":-31.949401,"marketCap":1074012179},{"date":"2020-10-09","current":-30.802785,"twenty":-37.298498,"median":-34.503678,"eighty":-31.871476,"marketCap":1038361879},{"date":"2020-10-16","current":-31.726757,"twenty":-37.285229,"median":-33.897535,"eighty":-31.826947,"marketCap":1069508983},{"date":"2020-10-23","current":-31.125619,"twenty":-37.281723,"median":-33.665444,"eighty":-31.749022,"marketCap":1049244602},{"date":"2020-10-30","current":-27.529919,"twenty":-37.16581,"median":-33.313095,"eighty":-31.613224,"marketCap":928033584},{"date":"2020-11-06","current":-31.147883,"twenty":-37.152541,"median":-33.245062,"eighty":-31.420435,"marketCap":1049995135},{"date":"2020-11-13","current":-28.475809,"twenty":-37.148136,"median":-33.185075,"eighty":-31.147883,"marketCap":1095777625},{"date":"2020-11-20","current":-28.924401,"twenty":-37.112735,"median":-32.711956,"eighty":-30.969768,"marketCap":1113039875},{"date":"2020-11-27","current":-29.967864,"twenty":-36.97474,"median":-32.628465,"eighty":-30.631349,"marketCap":1153193370},{"date":"2020-12-04","current":-31.71347,"twenty":-36.937348,"median":-32.283367,"eighty":-30.353044,"marketCap":1220366040},{"date":"2020-12-11","current":-31.37215,"twenty":-36.722887,"median":-32.366858,"eighty":-30.408705,"marketCap":1207231719},{"date":"2020-12-18","current":-28.007714,"twenty":-36.620708,"median":-32.261103,"eighty":-30.184146,"marketCap":1077764842},{"date":"2020-12-24","current":-28.778121,"twenty":-36.497064,"median":-32.160913,"eighty":-30.079555,"marketCap":1107410880},{"date":"2020-12-31","current":-24.887077,"twenty":-36.316609,"median":-32.105252,"eighty":-29.407768,"marketCap":957679623},{"date":"2021-01-08","current":-27.451851,"twenty":-36.149868,"median":-32.005062,"eighty":-29.207279,"marketCap":1056374662},{"date":"2021-01-15","current":-25.803764,"twenty":-36.130188,"median":-31.860343,"eighty":-29.125292,"marketCap":992954656},{"date":"2021-01-22","current":-25.238149,"twenty":-36.089914,"median":-31.826947,"eighty":-28.936103,"marketCap":971189210},{"date":"2021-01-29","current":-22.312552,"twenty":-35.97035,"median":-31.754588,"eighty":-28.475809,"marketCap":858609317},{"date":"2021-02-05","current":-21.883465,"twenty":-35.92353,"median":-31.737889,"eighty":-28.025268,"marketCap":842097599},{"date":"2021-02-12","current":-21.727433,"twenty":-35.862817,"median":-31.708982,"eighty":-27.465504,"marketCap":836093338},{"date":"2021-02-19","current":-25.228397,"twenty":-35.799127,"median":-31.653595,"eighty":-26.778963,"marketCap":970813943},{"date":"2021-02-26","current":-23.531551,"twenty":-35.746052,"median":-31.486779,"eighty":-26.086572,"marketCap":905517606},{"date":"2021-03-05","current":-22.390568,"twenty":-35.653171,"median":-31.396293,"eighty":-25.940292,"marketCap":861611447},{"date":"2021-03-12","current":-25.004101,"twenty":-35.638406,"median":-31.225808,"eighty":-25.238149,"marketCap":962182818},{"date":"2021-03-19","current":-21.412757,"twenty":-35.321452,"median":-31.064391,"eighty":-25.004101,"marketCap":949762842},{"date":"2021-03-26","current":-17.828429,"twenty":-35.215302,"median":-30.969768,"eighty":-24.887077,"marketCap":790779984},{"date":"2021-04-01","current":-18.989311,"twenty":-35.024232,"median":-30.680331,"eighty":-24.762252,"marketCap":842270886},{"date":"2021-04-09","current":-18.72663,"twenty":-34.718913,"median":-30.446554,"eighty":-23.687583,"marketCap":830619660},{"date":"2021-04-16","current":-17.582695,"twenty":-34.413171,"median":-30.201646,"eighty":-23.329342,"marketCap":779880450},{"date":"2021-04-23","current":-19.048626,"twenty":-34.331602,"median":-30.09464,"eighty":-22.642588,"marketCap":844901808},{"date":"2021-04-30","current":-19.878228,"twenty":-34.264448,"median":-29.967864,"eighty":-22.388618,"marketCap":881698811},{"date":"2021-05-07","current":-18.504392,"twenty":-33.967825,"median":-29.319357,"eighty":-21.984885,"marketCap":820762289},{"date":"2021-05-14","current":-12.366031,"twenty":-33.808477,"median":-29.222013,"eighty":-21.780094,"marketCap":768103629},{"date":"2021-05-21","current":-13.322854,"twenty":-33.708758,"median":-29.156835,"eighty":-21.678673,"marketCap":827535742},{"date":"2021-05-28","current":-14.37657,"twenty":-33.651075,"median":-29.109689,"eighty":-21.248369,"marketCap":892986296},{"date":"2021-06-04","current":-13.528752,"twenty":-33.48787,"median":-28.982913,"eighty":-20.919439,"marketCap":840324930},{"date":"2021-06-11","current":-15.533236,"twenty":-33.342039,"median":-28.773245,"eighty":-20.304412,"marketCap":964831444},{"date":"2021-06-18","current":-16.235714,"twenty":-33.276359,"median":-28.475809,"eighty":-19.944808,"marketCap":1008465147},{"date":"2021-06-25","current":-17.719396,"twenty":-33.251868,"median":-28.20763,"eighty":-18.985306,"marketCap":1100622536},{"date":"2021-07-02","current":-14.3039,"twenty":-33.243701,"median":-27.69565,"eighty":-18.607999,"marketCap":888472464},{"date":"2021-07-09","current":-15.266779,"twenty":-33.225889,"median":-27.520114,"eighty":-18.486902,"marketCap":948280729},{"date":"2021-07-16","current":-13.777042,"twenty":-33.198433,"median":-27.183671,"eighty":-17.913165,"marketCap":855747187},{"date":"2021-07-23","current":-13.316798,"twenty":-33.073753,"median":-26.730203,"eighty":-17.637375,"marketCap":827159589},{"date":"2021-07-30","current":-11.693832,"twenty":-32.854637,"median":-26.218224,"eighty":-17.10309,"marketCap":726350689},{"date":"2021-08-06","current":-14.746344,"twenty":-32.752871,"median":-26.067068,"eighty":-16.259938,"marketCap":915954440},{"date":"2021-08-13","current":-11.436404,"twenty":-32.71307,"median":-25.872028,"eighty":-15.828761,"marketCap":891021641},{"date":"2021-08-20","current":-11.81156,"twenty":-32.688579,"median":-25.374677,"eighty":-15.39153,"marketCap":920250439},{"date":"2021-08-27","current":-11.881902,"twenty":-32.635144,"median":-25.223521,"eighty":-15.121439,"marketCap":925730839},{"date":"2021-09-03","current":-11.278135,"twenty":-32.554492,"median":-25.004101,"eighty":-14.763154,"marketCap":878690742},{"date":"2021-09-10","current":-13.224258,"twenty":-32.484973,"median":-24.974845,"eighty":-14.543711,"marketCap":1030315132},{"date":"2021-09-17","current":-14.044912,"twenty":-32.416953,"median":-24.862697,"eighty":-14.441383,"marketCap":1094253128},{"date":"2021-09-24","current":-13.734236,"twenty":-32.283367,"median":-24.779805,"eighty":-14.366881,"marketCap":1070048029},{"date":"2021-10-01","current":-13.611137,"twenty":-32.278914,"median":-24.024026,"eighty":-14.14795,"marketCap":1060457330},{"date":"2021-10-08","current":-13.441145,"twenty":-32.243291,"median":-23.531551,"eighty":-14.069443,"marketCap":1047213031},{"date":"2021-10-15","current":-12.614629,"twenty":-32.169819,"median":-23.441741,"eighty":-13.946434,"marketCap":982818335},{"date":"2021-10-22","current":-13.001509,"twenty":-32.160913,"median":-22.956183,"eighty":-13.742797,"marketCap":1012960533},{"date":"2021-10-29","current":-13.189087,"twenty":-32.149781,"median":-22.581778,"eighty":-13.630951,"marketCap":1027574932},{"date":"2021-11-05","current":-15.299341,"twenty":-32.09711,"median":-22.410072,"eighty":-13.655687,"marketCap":1191986921},{"date":"2021-11-12","current":-12.166812,"twenty":-32.063778,"median":-22.346684,"eighty":-13.593676,"marketCap":1164923541},{"date":"2021-11-19","current":-13.7195,"twenty":-32.038459,"median":-22.01024,"eighty":-13.566299,"marketCap":1313587294},{"date":"2021-11-26","current":-11.863131,"twenty":-31.949401,"median":-21.834705,"eighty":-13.499763,"marketCap":1135847350},{"date":"2021-12-03","current":-11.363528,"twenty":-31.871476,"median":-21.771317,"eighty":-13.400112,"marketCap":1088012325},{"date":"2021-12-10","current":-11.936602,"twenty":-31.860343,"median":-21.688425,"eighty":-13.322854,"marketCap":1142881912},{"date":"2021-12-17","current":-11.363528,"twenty":-31.849211,"median":-21.545715,"eighty":-13.25624,"marketCap":1088012325},{"date":"2021-12-23","current":-12.543963,"twenty":-31.8314,"median":-21.349205,"eighty":-13.175019,"marketCap":1201034295},{"date":"2021-12-31","current":-11.642718,"twenty":-31.820188,"median":-20.980345,"eighty":-13.050829,"marketCap":1114743662},{"date":"2022-01-07","current":-9.389605,"twenty":-31.771823,"median":-20.760217,"eighty":-12.953442,"marketCap":899017081},{"date":"2022-01-14","current":-8.733263,"twenty":-31.751248,"median":-20.311191,"eighty":-12.90702,"marketCap":836174989},{"date":"2022-01-21","current":-6.965059,"twenty":-31.742342,"median":-20.064799,"eighty":-12.792452,"marketCap":666876520},{"date":"2022-01-28","current":-7.464662,"twenty":-31.737889,"median":-19.933711,"eighty":-12.673256,"marketCap":714711544},{"date":"2022-02-04","current":-7.969164,"twenty":-31.73121,"median":-19.0217,"eighty":-12.607595,"marketCap":763015540},{"date":"2022-02-11","current":-7.85161,"twenty":-31.718785,"median":-18.924175,"eighty":-12.532803,"marketCap":751760240},{"date":"2022-02-18","current":-7.312822,"twenty":-31.708084,"median":-18.658841,"eighty":-12.451927,"marketCap":700173449},{"date":"2022-02-25","current":-8.013246,"twenty":-31.700282,"median":-18.504392,"eighty":-12.34642,"marketCap":767236277},{"date":"2022-03-04","current":-6.42211,"twenty":-31.661669,"median":-18.41632,"eighty":-12.182486,"marketCap":757866723},{"date":"2022-03-11","current":-7.093861,"twenty":-31.575306,"median":-18.040269,"eighty":-12.09334,"marketCap":837139487},{"date":"2022-03-18","current":-7.478298,"twenty":-31.50577,"median":-17.752167,"eighty":-11.945203,"marketCap":882506430},{"date":"2022-03-25","current":-7.004834,"twenty":-31.476164,"median":-17.582695,"eighty":-11.873443,"marketCap":826633458},{"date":"2022-04-01","current":-8.097442,"twenty":-31.444319,"median":-17.294593,"eighty":-11.825906,"marketCap":955571086},{"date":"2022-04-08","current":-7.988182,"twenty":-31.401121,"median":-16.853967,"eighty":-11.719268,"marketCap":942677323},{"date":"2022-04-14","current":-7.373084,"twenty":-31.365146,"median":-16.296273,"eighty":-11.643698,"marketCap":870090214},{"date":"2022-04-22","current":-6.745845,"twenty":-31.314866,"median":-16.08129,"eighty":-11.54955,"marketCap":796070465},{"date":"2022-04-29","current":-6.030185,"twenty":-31.210223,"median":-15.799693,"eighty":-11.378103,"marketCap":711616090},{"date":"2022-05-06","current":-5.726567,"twenty":-31.14343,"median":-15.63013,"eighty":-11.319167,"marketCap":675786469},{"date":"2022-05-13","current":-5.018968,"twenty":-31.101128,"median":-15.299341,"eighty":-11.132571,"marketCap":644435550},{"date":"2022-05-20","current":-5.018968,"twenty":-30.999044,"median":-15.266779,"eighty":-10.917803,"marketCap":644435550},{"date":"2022-05-27","current":-5.670078,"twenty":-30.980006,"median":-15.085104,"eighty":-10.201035,"marketCap":728038000},{"date":"2022-06-03","current":-5.080979,"twenty":-30.969768,"median":-14.994266,"eighty":-9.134905,"marketCap":652397688},{"date":"2022-06-10","current":-4.918202,"twenty":-30.802785,"median":-14.767356,"eighty":-8.321825,"marketCap":631497076},{"date":"2022-06-17","current":-4.976336,"twenty":-30.680331,"median":-14.582469,"eighty":-8.263048,"marketCap":638961580},{"date":"2022-06-24","current":-5.511176,"twenty":-30.671425,"median":-14.503743,"eighty":-8.133739,"marketCap":707635021},{"date":"2022-07-01","current":-5.991757,"twenty":-30.517801,"median":-14.446601,"eighty":-8.061832,"marketCap":769341591},{"date":"2022-07-08","current":-6.615737,"twenty":-30.439875,"median":-14.434107,"eighty":-8.00322,"marketCap":849460606},{"date":"2022-07-15","current":-6.794017,"twenty":-30.3998,"median":-14.37657,"eighty":-7.922142,"marketCap":872351753},{"date":"2022-07-22","current":-6.418079,"twenty":-30.277345,"median":-14.265264,"eighty":-7.829079,"marketCap":824081291},{"date":"2022-07-29","current":-6.313436,"twenty":-30.149145,"median":-14.128281,"eighty":-7.661565,"marketCap":810645183},{"date":"2022-08-05","current":-7.359862,"twenty":-30.102442,"median":-14.079861,"eighty":-7.498145,"marketCap":945006263},{"date":"2022-08-12","current":-7.744765,"twenty":-30.09464,"median":-14.061667,"eighty":-7.476679,"marketCap":1144188352},{"date":"2022-08-19","current":-7.3884,"twenty":-30.072013,"median":-14.02967,"eighty":-7.470415,"marketCap":1091540050},{"date":"2022-08-26","current":-7.741237,"twenty":-30.00349,"median":-13.904228,"eighty":-7.470415,"marketCap":1143667082},{"date":"2022-09-02","current":-7.501308,"twenty":-29.680657,"median":-13.816405,"eighty":-7.464662,"marketCap":1108220700},{"date":"2022-09-09","current":-7.363701,"twenty":-29.434907,"median":-13.754752,"eighty":-7.442192,"marketCap":1087891157},{"date":"2022-09-16","current":-7.349588,"twenty":-29.326183,"median":-13.669756,"eighty":-7.391986,"marketCap":1085806076},{"date":"2022-09-23","current":-6.541592,"twenty":-29.285225,"median":-13.638908,"eighty":-7.361398,"marketCap":966435173},{"date":"2022-09-30","current":-5.761823,"twenty":-29.25994,"median":-13.589311,"eighty":-7.336663,"marketCap":851234432},{"date":"2022-10-07","current":-5.779465,"twenty":-29.212191,"median":-13.561735,"eighty":-7.29548,"marketCap":853840784},{"date":"2022-10-14","current":-5.79005,"twenty":-29.181854,"median":-13.499763,"eighty":-7.22525,"marketCap":855404595},{"date":"2022-10-21","current":-5.020866,"twenty":-29.157157,"median":-13.418819,"eighty":-7.180208,"marketCap":741767665},{"date":"2022-10-28","current":-5.130245,"twenty":-29.152611,"median":-13.388388,"eighty":-7.120264,"marketCap":757927045},{"date":"2022-11-04","current":-4.784465,"twenty":-29.133094,"median":-13.325882,"eighty":-7.077936,"marketCap":706842553},{"date":"2022-11-11","current":-4.987127,"twenty":-29.082383,"median":-13.286519,"eighty":-7.007322,"marketCap":808223767},{"date":"2022-11-18","current":-4.076405,"twenty":-29.01802,"median":-13.240249,"eighty":-6.959181,"marketCap":660630343},{"date":"2022-11-25","current":-4.210829,"twenty":-28.971211,"median":-13.206672,"eighty":-6.908542,"marketCap":682415350},{"date":"2022-12-02","current":-3.908375,"twenty":-28.895145,"median":-13.107021,"eighty":-6.819609,"marketCap":633399084},{"date":"2022-12-09","current":-3.666412,"twenty":-28.776171,"median":-13.032334,"eighty":-6.759911,"marketCap":594186071},{"date":"2022-12-16","current":-7.552337,"twenty":-28.709857,"median":-12.972199,"eighty":-6.729659,"marketCap":1223946832},{"date":"2022-12-23","current":-8.569155,"twenty":-28.475809,"median":-12.939832,"eighty":-6.746629,"marketCap":1388734462},{"date":"2022-12-30","current":-9.098065,"twenty":-28.475809,"median":-12.916512,"eighty":-6.749766,"marketCap":1474450608},{"date":"2023-01-06","current":-8.130447,"twenty":-28.468007,"median":-12.870801,"eighty":-6.757262,"marketCap":1317636573},{"date":"2023-01-13","current":-9.286668,"twenty":-28.349034,"median":-12.790483,"eighty":-6.762237,"marketCap":1505016056},{"date":"2023-01-20","current":-9.212867,"twenty":-28.1852,"median":-12.679109,"eighty":-6.781615,"marketCap":1493055663},{"date":"2023-01-27","current":-9.622875,"twenty":-28.042821,"median":-12.668823,"eighty":-6.805644,"marketCap":1559502288},{"date":"2023-02-03","current":-9.90988,"twenty":-27.820476,"median":-12.614629,"eighty":-6.815441,"marketCap":1606014926},{"date":"2023-02-10","current":-9.319469,"twenty":-27.596211,"median":-12.557946,"eighty":-6.825218,"marketCap":1510331786},{"date":"2023-02-17","current":-10.516691,"twenty":-27.524036,"median":-12.524371,"eighty":-6.862225,"marketCap":1704355931},{"date":"2023-02-24","current":-9.335869,"twenty":-27.492809,"median":-12.493203,"eighty":-6.889742,"marketCap":1512989651},{"date":"2023-03-03","current":-10.035487,"twenty":-27.440149,"median":-12.425244,"eighty":-6.901778,"marketCap":1746124614},{"date":"2023-03-10","current":-8.354767,"twenty":-27.231456,"median":-12.333346,"eighty":-6.912071,"marketCap":1453687685},{"date":"2023-03-17","current":-8.346628,"twenty":-26.878433,"median":-12.20808,"eighty":-6.923154,"marketCap":1452271526},{"date":"2023-03-24","current":-8.15129,"twenty":-26.759459,"median":-12.160132,"eighty":-6.936445,"marketCap":1418283699},{"date":"2023-03-31","current":-6.246745,"twenty":-26.718501,"median":-12.09334,"eighty":-6.923154,"marketCap":1086902385},{"date":"2023-04-06","current":-5.514228,"twenty":-26.630733,"median":-12.022319,"eighty":-6.88645,"marketCap":959448034},{"date":"2023-04-14","current":-6.210119,"twenty":-26.297215,"median":-11.936602,"eighty":-6.814077,"marketCap":1080529667},{"date":"2023-04-21","current":-6.409527,"twenty":-26.086572,"median":-11.881733,"eighty":-6.75164,"marketCap":1115225574},{"date":"2023-04-28","current":-5.921182,"twenty":-26.082671,"median":-11.863131,"eighty":-6.746629,"marketCap":1030256007},{"date":"2023-05-05","current":-4.55822,"twenty":-26.057316,"median":-11.826396,"eighty":-6.654268,"marketCap":793107504},{"date":"2023-05-12","current":-4.123772,"twenty":-26.002705,"median":-11.770068,"eighty":-6.61586,"marketCap":792399372},{"date":"2023-05-19","current":-3.939845,"twenty":-25.912986,"median":-11.705944,"eighty":-6.582075,"marketCap":757056927},{"date":"2023-05-26","current":-4.028298,"twenty":-25.768657,"median":-11.642718,"eighty":-6.532696,"marketCap":774053528},{"date":"2023-06-02","current":-4.006185,"twenty":-25.628229,"median":-11.606396,"eighty":-6.507219,"marketCap":769804377},{"date":"2023-06-09","current":-4.38211,"twenty":-25.425387,"median":-11.536054,"eighty":-6.447533,"marketCap":842039931},{"date":"2023-06-16","current":-4.599557,"twenty":-25.265455,"median":-11.451058,"eighty":-6.417304,"marketCap":883823241},{"date":"2023-06-23","current":-4.297342,"twenty":-25.232298,"median":-11.363528,"eighty":-6.355731,"marketCap":825751522},{"date":"2023-06-30","current":-4.087266,"twenty":-25.224496,"median":-11.343275,"eighty":-6.280747,"marketCap":785384595},{"date":"2023-07-07","current":-3.973015,"twenty":-25.19329,"median":-11.29572,"eighty":-6.217444,"marketCap":763430652},{"date":"2023-07-14","current":-4.083581,"twenty":-25.074315,"median":-11.149175,"eighty":-6.034901,"marketCap":784676403},{"date":"2023-07-21","current":-3.718712,"twenty":-25.0002,"median":-11.00556,"eighty":-5.918732,"marketCap":714565425},{"date":"2023-07-28","current":-3.353844,"twenty":-24.982647,"median":-10.912905,"eighty":-5.893783,"marketCap":644454447},{"date":"2023-08-04","current":-3.449668,"twenty":-24.963143,"median":-10.690816,"eighty":-5.812632,"marketCap":662867431},{"date":"2023-08-11","current":-3.431213,"twenty":-24.910482,"median":-10.45519,"eighty":-5.790085,"marketCap":663902014},{"date":"2023-08-18","current":-3.15932,"twenty":-24.877325,"median":-10.098356,"eighty":-5.73622,"marketCap":611293707},{"date":"2023-08-25","current":-3.036777,"twenty":-24.830515,"median":-9.963181,"eighty":-5.694292,"marketCap":587582921},{"date":"2023-09-01","current":-2.895086,"twenty":-24.795408,"median":-9.92423,"eighty":-5.645386,"marketCap":560167324},{"date":"2023-09-08","current":-2.657658,"twenty":-24.779805,"median":-9.89937,"eighty":-5.620688,"marketCap":514227676},{"date":"2023-09-15","current":-2.79169,"twenty":-24.692038,"median":-9.799178,"eighty":-5.507781,"marketCap":540161349},{"date":"2023-09-22","current":-2.665317,"twenty":-24.321462,"median":-9.686426,"eighty":-5.398782,"marketCap":515709600},{"date":"2023-09-29","current":-2.512138,"twenty":-23.726591,"median":-9.659775,"eighty":-5.29414,"marketCap":486071117},{"date":"2023-10-06","current":-2.385765,"twenty":-23.726591,"median":-9.633125,"eighty":-5.197248,"marketCap":461619369},{"date":"2023-10-13","current":-2.339812,"twenty":-23.531551,"median":-9.508072,"eighty":-5.09849,"marketCap":452727824},{"date":"2023-10-20","current":-2.113872,"twenty":-23.531551,"median":-9.377088,"eighty":-5.020866,"marketCap":409011062},{"date":"2023-10-27","current":-2.021965,"twenty":-23.52765,"median":-9.35022,"eighty":-5.018968,"marketCap":391227972},{"date":"2023-11-03","current":-1.937716,"twenty":-23.457752,"median":-9.319469,"eighty":-4.995462,"marketCap":374926807},{"date":"2023-11-10","current":-2.007807,"twenty":-23.297002,"median":-9.252089,"eighty":-4.97662,"marketCap":406074871},{"date":"2023-11-17","current":-2.172681,"twenty":-23.102463,"median":-9.208767,"eighty":-4.944556,"marketCap":439420436},{"date":"2023-11-24","current":-2.293589,"twenty":-22.944481,"median":-9.098065,"eighty":-4.9058,"marketCap":463873850},{"date":"2023-12-01","current":-2.861491,"twenty":-22.854762,"median":-9.062046,"eighty":-4.817675,"marketCap":578730793},{"date":"2023-12-08","current":-2.949424,"twenty":-22.642588,"median":-9.020164,"eighty":-4.736046,"marketCap":596515094},{"date":"2023-12-15","current":-2.942096,"twenty":-22.478734,"median":-8.888495,"eighty":-4.694967,"marketCap":595033069},{"date":"2023-12-22","current":-3.326804,"twenty":-22.459579,"median":-8.782359,"eighty":-4.625203,"marketCap":672839386},{"date":"2023-12-29","current":-3.418401,"twenty":-22.422449,"median":-8.716971,"eighty":-4.575798,"marketCap":691364699},{"date":"2024-01-05","current":-3.605259,"twenty":-22.40227,"median":-8.619287,"eighty":-4.546011,"marketCap":729156339},{"date":"2024-01-12","current":-4.121866,"twenty":-22.386667,"median":-8.480923,"eighty":-4.474248,"marketCap":833639107},{"date":"2024-01-19","current":-3.821428,"twenty":-22.367163,"median":-8.410527,"eighty":-4.373264,"marketCap":772876079},{"date":"2024-01-26","current":-4.11118,"twenty":-22.291896,"median":-8.346628,"eighty":-4.316264,"marketCap":831478023},{"date":"2024-02-02","current":-4.766927,"twenty":-22.169467,"median":-8.324274,"eighty":-4.333222,"marketCap":964101547},{"date":"2024-02-09","current":-4.912213,"twenty":-21.984885,"median":-8.302651,"eighty":-4.337146,"marketCap":993485202},{"date":"2024-02-16","current":-5.312729,"twenty":-21.873713,"median":-8.279699,"eighty":-4.353363,"marketCap":1074488792},{"date":"2024-02-23","current":-5.709318,"twenty":-21.834705,"median":-8.254149,"eighty":-4.371053,"marketCap":1154698229},{"date":"2024-03-01","current":-6.884704,"twenty":-21.815201,"median":-8.220472,"eighty":-4.38211,"marketCap":1461071871},{"date":"2024-03-08","current":-7.531791,"twenty":-21.785945,"median":-8.189978,"eighty":-4.452135,"marketCap":1598396659},{"date":"2024-03-15","current":-9.017834,"twenty":-21.756689,"median":-8.204249,"eighty":-4.466877,"marketCap":1913764632},{"date":"2024-03-22","current":-9.066741,"twenty":-21.727433,"median":-8.229515,"eighty":-4.485305,"marketCap":1924143831},{"date":"2024-03-28","current":-9.281183,"twenty":-21.696227,"median":-8.254149,"eighty":-4.491202,"marketCap":1969652627},{"date":"2024-04-05","current":-10.661495,"twenty":-21.680623,"median":-8.292436,"eighty":-4.519064,"marketCap":2262582364},{"date":"2024-04-12","current":-11.408564,"twenty":-21.678673,"median":-8.304891,"eighty":-4.535429,"marketCap":2421125493},{"date":"2024-04-19","current":-10.368967,"twenty":-21.46594,"median":-8.326723,"eighty":-4.55415,"marketCap":2200502223},{"date":"2024-04-26","current":-10.7245,"twenty":-21.412757,"median":-8.350698,"eighty":-4.564979,"marketCap":2275953471},{"date":"2024-05-03","current":-11.526166,"twenty":-21.311074,"median":-8.417453,"eighty":-4.569664,"marketCap":2446082844},{"date":"2024-05-10","current":-12.211067,"twenty":-21.136518,"median":-8.528949,"eighty":-4.570559,"marketCap":2591432567},{"date":"2024-05-17","current":-12.011,"twenty":-21.004123,"median":-8.619287,"eighty":-4.575834,"marketCap":2746687402},{"date":"2024-05-24","current":-11.488237,"twenty":-20.980345,"median":-8.728825,"eighty":-4.595074,"marketCap":2627141467},{"date":"2024-05-31","current":-11.316771,"twenty":-20.888986,"median":-8.784409,"eighty":-4.609363,"marketCap":2587930400},{"date":"2024-06-07","current":-10.890196,"twenty":-20.746644,"median":-8.909462,"eighty":-4.626414,"marketCap":2490380917},{"date":"2024-06-14","current":-16.711683,"twenty":-20.65513,"median":-8.938982,"eighty":-4.645017,"marketCap":3821644450},{"date":"2024-06-21","current":-17.463994,"twenty":-20.541673,"median":-9.002785,"eighty":-4.663959,"marketCap":3993683592},{"date":"2024-06-28","current":-18.824523,"twenty":-20.426432,"median":-9.017834,"eighty":-4.66706,"marketCap":4304810763},{"date":"2024-07-05","current":-17.278256,"twenty":-20.304412,"median":-9.028364,"eighty":-4.67213,"marketCap":3951208893},{"date":"2024-07-12","current":-20.575102,"twenty":-20.304412,"median":-9.060735,"eighty":-4.682062,"marketCap":4705134803},{"date":"2024-07-15","current":-20.80263,"twenty":-20.416755,"median":-9.066741,"eighty":-4.685549,"marketCap":4757166310},{"date":"2024-08-02","current":-20.695831,"twenty":-20.57994,"median":-9.068053,"eighty":-4.689037,"marketCap":4732743358},{"date":"2024-08-09","current":-19.442101,"twenty":-20.389364,"median":-9.098065,"eighty":-4.702292,"marketCap":4446039138},{"date":"2024-08-16","current":-21.104668,"twenty":-20.45155,"median":-9.161017,"eighty":-4.704816,"marketCap":5327852349},{"date":"2024-08-23","current":-19.882184,"twenty":-20.693049,"median":-9.212867,"eighty":-4.711267,"marketCap":5019237468},{"date":"2024-08-30","current":-19.782437,"twenty":-20.617905,"median":-9.283926,"eighty":-4.724704,"marketCap":4994056368},{"date":"2024-09-06","current":-18.910228,"twenty":-20.584778,"median":-9.305118,"eighty":-4.728041,"marketCap":4773868141},{"date":"2024-09-13","current":-19.165395,"twenty":-20.528184,"median":-9.335869,"eighty":-4.751474,"marketCap":4838284910},{"date":"2024-09-20","current":-21.178899,"twenty":-20.584778,"median":-9.377088,"eighty":-4.766927,"marketCap":5346591773},{"date":"2024-09-27","current":-19.564385,"twenty":-20.614011,"median":-9.508072,"eighty":-4.767001,"marketCap":4939009311},{"date":"2024-10-04","current":-21.828416,"twenty":-20.69977,"median":-9.611919,"eighty":-4.777499,"marketCap":5510561728},{"date":"2024-10-11","current":-20.515463,"twenty":-20.808388,"median":-9.644811,"eighty":-4.795146,"marketCap":5179108175},{"date":"2024-10-18","current":-22.510409,"twenty":-20.924108,"median":-9.672717,"eighty":-4.8043,"marketCap":5682730182},{"date":"2024-10-25","current":-20.946928,"twenty":-21.062913,"median":-9.717176,"eighty":-4.807671,"marketCap":5288031074},{"date":"2024-10-31","current":-20.051522,"twenty":-21.062913,"median":-9.811478,"eighty":-4.820452,"marketCap":5061986778},{"date":"2024-11-08","current":-19.838416,"twenty":-21.062913,"median":-9.907571,"eighty":-4.84349,"marketCap":5564437571},{"date":"2024-11-15","current":-21.255407,"twenty":-21.084706,"median":-9.93858,"eighty":-4.869368,"marketCap":5961886570},{"date":"2024-11-22","current":-18.103464,"twenty":-21.062913,"median":-9.999334,"eighty":-4.898048,"marketCap":5077804531},{"date":"2024-11-29","current":-18.303385,"twenty":-21.046399,"median":-10.098356,"eighty":-4.902699,"marketCap":5133879910},{"date":"2024-12-06","current":-15.687401,"twenty":-20.980345,"median":-10.127184,"eighty":-4.904602,"marketCap":4400127610},{"date":"2024-12-13","current":-14.360267,"twenty":-20.973662,"median":-10.412078,"eighty":-4.913411,"marketCap":4027882541},{"date":"2024-12-20","current":-13.207532,"twenty":-20.943217,"median":-10.598489,"eighty":-4.922504,"marketCap":3704554292},{"date":"2024-12-27","current":-13.237308,"twenty":-20.928371,"median":-10.661495,"eighty":-4.939713,"marketCap":3712905945},{"date":"2025-01-03","current":-13.262829,"twenty":-20.920948,"median":-10.736574,"eighty":-4.941107,"marketCap":3720064504},{"date":"2025-01-10","current":-12.731125,"twenty":-20.899606,"median":-10.760504,"eighty":-4.946106,"marketCap":3570927857},{"date":"2025-01-17","current":-12.033529,"twenty":-20.875481,"median":-10.849125,"eighty":-4.95057,"marketCap":3375260577},{"date":"2025-01-24","current":-12.816198,"twenty":-20.852067,"median":-10.87291,"eighty":-4.952418,"marketCap":3594789721},{"date":"2025-01-31","current":-13.879606,"twenty":-20.823658,"median":-10.890196,"eighty":-4.960884,"marketCap":3893063013},{"date":"2025-02-07","current":-14.934507,"twenty":-20.811267,"median":-10.956919,"eighty":-4.973416,"marketCap":4188950119},{"date":"2025-02-14","current":-14.045498,"twenty":-20.799109,"median":-11.007295,"eighty":-4.97662,"marketCap":3939593647},{"date":"2025-02-21","current":-13.83707,"twenty":-20.776198,"median":-11.084534,"eighty":-4.979061,"marketCap":3881132082},{"date":"2025-02-28","current":-10.764795,"twenty":-20.703709,"median":-11.126407,"eighty":-4.987294,"marketCap":3469514938},{"date":"2025-03-07","current":-11.319953,"twenty":-20.695136,"median":-11.124394,"eighty":-4.988898,"marketCap":3648443335},{"date":"2025-03-14","current":-11.983857,"twenty":-20.689452,"median":-11.128498,"eighty":-4.99405,"marketCap":3862421231},{"date":"2025-03-21","current":-11.498983,"twenty":-20.669492,"median":-11.149175,"eighty":-5.000402,"marketCap":3706145239},{"date":"2025-03-28","current":-12.144239,"twenty":-20.628729,"median":-11.183518,"eighty":-5.004574,"marketCap":3914112520},{"date":"2025-04-04","current":-10.480747,"twenty":-20.594455,"median":-11.15204,"eighty":-5.011771,"marketCap":3377965658},{"date":"2025-04-11","current":-8.992555,"twenty":-20.563174,"median":-11.12911,"eighty":-5.018968,"marketCap":2898318577}],"updateTime":1744482464720}}}